Overall, despite the initial findings pointing towards a hereditary syndrome, a thorough workup by multidisciplinary teams, including additional germline and somatic (tumor) molecular testing, favored this tumor to be a sporadic UBPGL with a novel somatic SDHB variant. The gene discussed is SDHB; the disease is Down syndrome.